Jianlin Geng
Hengshui, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes.
Journal: Nature
Published: June 16, 2025
Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 study.
Journal: Journal of diabetes investigation
Published: September 18, 2024
Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study.
Journal: Current medical research and opinion
Published: September 05, 2024
Serum Gamma Glutamyltransferase: A Biomarker for Identifying Postprandial Hypertriglyceridemia.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: January 29, 2024
Relationship of postprandial fibroblast growth factor 21 with lipids, inflammation and metabolic dysfunction-associated fatty liver disease during oral fat tolerance test.
Journal: Frontiers in endocrinology
Published: November 24, 2023
Serum Fibroblast Growth Factor 21 Level After an Oral Fat Tolerance Test is Related to Postprandial Free Fatty Acid Level.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: March 10, 2023
Analysis of the Application Value of Ultrasound Three-Dimensional Speckle Tracking Technology Combined with Thyroid Autoantibodies and Hormones in the Diagnosis and Treatment of Graves' Disease.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: April 18, 2022
Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes: A 24-week, multi-centre, randomized, double-blind, placebo-controlled, superiority, phase III clinical trial.
Journal: Diabetes, obesity & metabolism
Published: March 17, 2022
Pterostilbene, a Resveratrol Derivative, Improves Ectopic Lipid Deposition in the Kidneys of Mice Induced by a High-Fat Diet.
Journal: Kidney & blood pressure research
Published: December 14, 2021
Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway.
Journal: European journal of pharmacology
Published: November 16, 2021
Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Journal: International journal of clinical practice
Published: October 20, 2021
Last Updated: 09/26/2026